| 1 | Microform holoprosencephaly | Enrichment | CRIPTO, DLL1, GLI2, PTCH1, SHH, SUFU | 7.41 |
| 2 | Loeys-dietz syndrome | Enrichment | SMAD2, SMAD3, TGFB2, TGFB3, TGFBR1 | 7.30 |
| 3 | Medulloblastoma | Enrichment | APC, CTNNB1, PTCH1, PTCH2, SUFU | 6.13 |
| 4 | Septopreoptic holoprosencephaly | Enrichment | CRIPTO, DLL1, GLI2, PTCH1, SHH | 5.96 |
| 5 | Midline interhemispheric variant of holoprosencephaly | Enrichment | CRIPTO, DLL1, GLI2, PTCH1, SHH | 5.96 |
| 6 | Lobar holoprosencephaly | Enrichment | CRIPTO, DLL1, GLI2, PTCH1, SHH | 5.80 |
| 7 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | NOTCH1, SMAD2, SMAD3, SMAD4, TGFB2, TGFB3, TGFBR1 | 5.76 |
| 8 | Alobar holoprosencephaly | Enrichment | CRIPTO, DLL1, GLI2, PTCH1, SHH | 5.65 |
| 9 | Semilobar holoprosencephaly | Enrichment | CRIPTO, DLL1, GLI2, PTCH1, SHH | 5.51 |
| 10 | Tooth agenesis, selective, 1 | Enrichment | AXIN2, BMPR2, MSX1, PAX9 | 5.43 |
| 11 | Basal cell nevus syndrome 1 | Enrichment | PTCH1, PTCH2, SUFU | 4.34 |
| 12 | Polycystic liver disease | Enrichment | CTNNB1, LRP5, LRP6, RUVBL1 | 4.19 |
| 13 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1, LRP5, LRP6, RUVBL1 | 4.19 |
| 14 | Adams-oliver syndrome | Enrichment | DLL4, NOTCH1, RBPJ | 4.10 |
| 15 | Osteopathia striata with cranial sclerosis | Enrichment | AMER1, CTNNB1 | 3.75 |
| 16 | Fibrodysplasia ossificans progressiva | Enrichment | ACVR1, BMPR2 | 3.75 |
| 17 | Loeys-dietz syndrome 4 | Enrichment | TGFB2, TGFB3 | 3.75 |
| 18 | Tooth agenesis | Enrichment | AXIN2, LRP6, MSX1, PAX9 | 3.72 |
| 19 | Heritable pulmonary arterial hypertension | Enrichment | BMPR2, ENG, SMAD9 | 3.44 |
| 20 | Desmoid disease, hereditary | Enrichment | APC, CTNNB1 | 3.27 |
| 21 | Osteoporosis, juvenile | Enrichment | DKK1, WNT3A | 3.27 |
| 22 | Alzheimer disease 4 | Enrichment | PSEN1, PSEN2 | 3.27 |
| 23 | Desmoid tumor | Enrichment | APC, CTNNB1 | 3.27 |
| 24 | Loeys-dietz syndrome 1 | Enrichment | SMAD2, TGFBR1 | 3.27 |
| 25 | Pulmonary arterial hypertension associated with congenital heart disease | Enrichment | BMPR2, SMAD9 | 3.27 |
| 26 | Keratoacanthoma | Enrichment | NOTCH1, NOTCH2 | 3.27 |
| 27 | Aortic valve disease 1 | Enrichment | NKX2-5, NOTCH1, TAB2 | 3.21 |
| 28 | Microphthalmia/coloboma 12 | Enrichment | FZD5, PAX2, YAP1 | 3.21 |
| 29 | Coloboma of macula | Enrichment | FZD5, PAX2, YAP1 | 3.02 |
| 30 | Polydactyly, preaxial ii | Enrichment | PTCH1, SHH | 2.98 |
| 31 | Robinow syndrome, autosomal dominant 1 | Enrichment | DVL3, WNT5A | 2.98 |
| 32 | Malignant epithelioid hemangioendothelioma | Enrichment | WWTR1, YAP1 | 2.98 |
| 33 | Aortic aneurysm | Enrichment | SMAD3, TGFBR1 | 2.98 |
| 34 | Craniopharyngioma | Enrichment | APC, CTNNB1 | 2.98 |
| 35 | Corneal dystrophy | Enrichment | TGFBI, ZEB1 | 2.98 |
| 36 | Autosomal dominant robinow syndrome | Enrichment | DVL3, WNT5A | 2.98 |
| 37 | Pseudomyogenic hemangioendothelioma | Enrichment | SERPINE1, WWTR1 | 2.98 |
| 38 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1, LRP5 | 2.76 |
| 39 | Robinow syndrome, autosomal recessive 1 | Enrichment | DVL3, WNT5A | 2.76 |
| 40 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | ENG, SMAD4 | 2.76 |
| 41 | Familial cerebral saccular aneurysm | Enrichment | ENG, TGFBR3 | 2.76 |
| 42 | Inherited cancer-predisposing syndrome | Enrichment | APC, AXIN2, CDC73, CYLD, PTCH1, SMAD4, SUFU | 2.70 |
| 43 | Macs syndrome | Enrichment | PTCH1, SHH, SOX2 | 2.64 |
| 44 | Atrial septal defect 1 | Enrichment | FOXP1, TGFB2 | 2.59 |
| 45 | Telangiectasia, hereditary hemorrhagic, type 1 | Enrichment | ENG, PSEN1 | 2.59 |
| 46 | Basal cell carcinoma 1 | Enrichment | PTCH1, PTCH2 | 2.59 |
| 47 | Autosomal recessive robinow syndrome | Enrichment | DVL3, WNT5A | 2.59 |
| 48 | Spondylocostal dysostosis, autosomal recessive | Enrichment | DLL3, LFNG | 2.59 |
| 49 | Hepatoblastoma | Enrichment | APC, CTNNB1, JAG1 | 2.58 |
| 50 | Hepatocellular carcinoma | Enrichment | APC, AXIN1, CTNNB1 | 2.52 |
| 51 | Gallbladder cancer | Enrichment | CTNNB1, SMAD4 | 2.44 |
| 52 | Hereditary hemorrhagic telangiectasia | Enrichment | ENG, SMAD4 | 2.44 |
| 53 | Early-onset autosomal dominant alzheimer disease | Enrichment | PSEN1, PSEN2 | 2.44 |
| 54 | Exudative vitreoretinopathy | Enrichment | CTNNB1, LRP5 | 2.32 |
| 55 | Hypoplastic left heart syndrome | Enrichment | NKX2-5, NOTCH1 | 2.32 |
| 56 | Tetralogy of fallot | Enrichment | JAG1, NKX2-5, NOTCH1 | 2.31 |
| 57 | Adult hepatocellular carcinoma | Enrichment | AXIN1, CTNNB1 | 2.22 |
| 58 | Progressive non-fluent aphasia | Enrichment | PSEN1, TBK1 | 2.22 |
| 59 | Colorectal cancer | Enrichment | AMER1, APC, AXIN2, CTNNB1, SMAD4 | 2.20 |
| 60 | Marfan syndrome | Enrichment | TGFB2, TGFBR1 | 2.12 |
| 61 | Migraine with or without aura 1 | Enrichment | NOTCH3, TAB2 | 2.04 |
| 62 | Septooptic dysplasia | Enrichment | SHH, SOX2 | 1.97 |
| 63 | Neural tube defects | Enrichment | SCRIB, VANGL1 | 1.90 |
| 64 | Pulmonary hypertension, primary, 1 | Enrichment | BMPR2, ENG | 1.90 |
| 65 | Holoprosencephaly 3 | Enrichment | SHH | 1.87 |
| 66 | Corneal dystrophy, epithelial basement membrane | Enrichment | TGFBI | 1.87 |
| 67 | Craniofacial-deafness-hand syndrome | Enrichment | PAX3 | 1.87 |
| 68 | Chiari malformation type i | Enrichment | DKK1 | 1.87 |
| 69 | Corneal dystrophy, groenouw type i | Enrichment | TGFBI | 1.87 |
| 70 | Atrial septal defect 7 with or without atrioventricular conduction defects | Enrichment | NKX2-5 | 1.87 |
| 71 | Cardiospondylocarpofacial syndrome | Enrichment | MAP3K7 | 1.87 |
| 72 | Endosteal hyperostosis, autosomal dominant | Enrichment | LRP5 | 1.87 |
| 73 | Nail disorder, nonsyndromic congenital, 1 | Enrichment | FZD6 | 1.87 |
| 74 | Waardenburg syndrome, type 3 | Enrichment | PAX3 | 1.87 |
| 75 | Chand syndrome | Enrichment | RIPK4 | 1.87 |
| 76 | Hypothyroidism, congenital, nongoitrous, 5 | Enrichment | NKX2-5 | 1.87 |
| 77 | Bone mineral density quantitative trait locus 1 | Enrichment | LRP5 | 1.87 |
| 78 | Exudative vitreoretinopathy 4 | Enrichment | LRP5 | 1.87 |
| 79 | Corneal dystrophy, avellino type | Enrichment | TGFBI | 1.87 |
| 80 | Spondylocostal dysostosis 3, autosomal recessive | Enrichment | LFNG | 1.87 |
| 81 | Immunodysregulation, polyendocrinopathy, and enteropathy, x-linked | Enrichment | FOXP3 | 1.87 |
| 82 | Oligodontia-colorectal cancer syndrome | Enrichment | AXIN2 | 1.87 |
| 83 | Parathyroid carcinoma | Enrichment | CDC73 | 1.87 |
| 84 | Schilbach-rott syndrome | Enrichment | PTCH1 | 1.87 |
| 85 | Stargardt disease 4 | Enrichment | PROM1 | 1.87 |
| 86 | Tooth agenesis, selective, 3 | Enrichment | PAX9 | 1.87 |
| 87 | Hypophosphatasia, adult | Enrichment | ALPL | 1.87 |
| 88 | Hajdu-cheney syndrome | Enrichment | NOTCH2 | 1.87 |
| 89 | Alagille syndrome 2 | Enrichment | NOTCH2 | 1.87 |
| 90 | Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development | Enrichment | YAP1 | 1.87 |
| 91 | Acne inversa, familial, 1 | Enrichment | NCSTN | 1.87 |
| 92 | Hyperparathyroidism 2 with jaw tumors | Enrichment | CDC73 | 1.87 |
| 93 | Memory quantitative trait locus | Enrichment | WWC1 | 1.87 |
| 94 | Microphthalmia/coloboma 5 | Enrichment | SHH | 1.87 |
| 95 | Polydactyly, preaxial i | Enrichment | GLI1 | 1.87 |
| 96 | Earlobe crease | Enrichment | FOXP1 | 1.87 |
| 97 | Corneal dystrophy, lattice type i | Enrichment | TGFBI | 1.87 |
| 98 | Lateral meningocele syndrome | Enrichment | NOTCH3 | 1.87 |
| 99 | Multiple self-healing squamous epithelioma | Enrichment | TGFBR1 | 1.87 |
| 100 | Dyskeratosis congenita, autosomal recessive 6 | Enrichment | PARN | 1.87 |
| 101 | Hypophosphatasia, childhood | Enrichment | ALPL | 1.87 |
| 102 | Tooth agenesis, selective, 7 | Enrichment | LRP6 | 1.87 |
| 103 | Caudal duplication anomaly | Enrichment | AXIN1 | 1.87 |
| 104 | Advanced sleep phase syndrome, familial, 2 | Enrichment | CSNK1D | 1.87 |
| 105 | Macular dystrophy, retinal, 2 | Enrichment | PROM1 | 1.87 |
| 106 | Culler-jones syndrome | Enrichment | GLI2 | 1.87 |
| 107 | Frontometaphyseal dysplasia 2 | Enrichment | MAP3K7 | 1.87 |
| 108 | Ectodermal dysplasia 17 with or without limb malformations | Enrichment | LEF1 | 1.87 |
| 109 | Exudative vitreoretinopathy 8 | Enrichment | LRP6 | 1.87 |
| 110 | Charcot-marie-tooth disease, axonal, type 2hh | Enrichment | JAG1 | 1.87 |
| 111 | Corneal dystrophy, thiel-behnke type | Enrichment | TGFBI | 1.87 |
| 112 | Alpha-fetoprotein, hereditary persistence of | Enrichment | AFP | 1.87 |
| 113 | Adams-oliver syndrome 6 | Enrichment | DLL4 | 1.87 |
| 114 | Polydactyly, postaxial, type a8 | Enrichment | GLI1 | 1.87 |
| 115 | Joubert syndrome 32 | Enrichment | SUFU | 1.87 |
| 116 | Osteogenesis imperfecta, type xx | Enrichment | MESD | 1.87 |
| 117 | Hyperemesis gravidarum | Enrichment | GDF15 | 1.87 |
| 118 | Microphthalmia, syndromic 6 | Enrichment | BMP4 | 1.87 |
| 119 | Bartsocas-papas syndrome 1 | Enrichment | RIPK4 | 1.87 |
| 120 | Immunodeficiency 110 with lymphoproliferation | Enrichment | STK4 | 1.87 |
| 121 | Orofacial cleft 11 | Enrichment | BMP4 | 1.87 |
| 122 | Epithelial-stromal tgfbi dystrophy | Enrichment | TGFBI | 1.87 |
| 123 | Plasminogen activator inhibitor-1 deficiency | Enrichment | SERPINE1 | 1.87 |
| 124 | Cardiomyopathy, dilated, 1v | Enrichment | PSEN2 | 1.87 |
| 125 | Osteoporosis-pseudoglioma syndrome | Enrichment | LRP5 | 1.87 |
| 126 | Deafness, autosomal dominant 23 | Enrichment | SIX1 | 1.87 |
| 127 | Uveal coloboma-cleft lip and palate-intellectual disability | Enrichment | YAP1 | 1.87 |
| 128 | Coronary artery disease, autosomal dominant 2 | Enrichment | LRP6 | 1.87 |
| 129 | Camurati-engelmann disease 2 | Enrichment | TGFB2 | 1.87 |
| 130 | Corneal dystrophy, lattice type iiia | Enrichment | TGFBI | 1.87 |
| 131 | Polycystic liver disease 4 with or without kidney cysts | Enrichment | LRP5 | 1.87 |
| 132 | Corneal dystrophy, reis-bucklers type | Enrichment | TGFBI | 1.87 |
| 133 | Autoimmune disease, multisystem, with facial dysmorphism | Enrichment | ITCH | 1.87 |
| 134 | Holoprosencephaly 9 | Enrichment | GLI2 | 1.87 |
| 135 | Granular corneal dystrophy | Enrichment | TGFBI | 1.87 |
| 136 | Cardiomyopathy, dilated, 1u | Enrichment | PSEN1 | 1.87 |
| 137 | Ventricular septal defect 3 | Enrichment | NKX2-5 | 1.87 |
| 138 | Iron overload | Enrichment | BMP6 | 1.87 |
| 139 | Craniosynostosis 3 | Enrichment | TCF12 | 1.87 |
| 140 | Pulmonary hypertension, primary, 2 | Enrichment | SMAD9 | 1.87 |
| 141 | Myofibromatosis, infantile, 2 | Enrichment | NOTCH3 | 1.87 |
| 142 | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 4 | Enrichment | PARN | 1.87 |
| 143 | Alpha-fetoprotein deficiency | Enrichment | AFP | 1.87 |
| 144 | Loeys-dietz syndrome 6 | Enrichment | SMAD2 | 1.87 |
| 145 | Retinitis pigmentosa 41 | Enrichment | PROM1 | 1.87 |
| 146 | Microphthalmia/coloboma 11 | Enrichment | FZD5 | 1.87 |
| 147 | Acne inversa, familial, 2, with or without dowling-degos disease | Enrichment | PSENEN | 1.87 |
| 148 | Autoinflammation with arthritis and vasculitis | Enrichment | TBK1 | 1.87 |
| 149 | Cdc73-related disorders | Enrichment | CDC73 | 1.87 |
| 150 | Choanal atresia and lymphedema | Enrichment | PTPN14 | 1.87 |
| 151 | Acne inversa, familial, 3 | Enrichment | PSEN1 | 1.87 |
| 152 | Hypoplastic left heart syndrome 2 | Enrichment | NKX2-5 | 1.87 |
| 153 | Loeys-dietz syndrome 5 | Enrichment | TGFB3 | 1.87 |
| 154 | Visual impairment and progressive phthisis bulbi | Enrichment | MARK3 | 1.87 |
| 155 | Muscular dystrophy, limb-girdle, autosomal recessive 27 | Enrichment | JAG2 | 1.87 |
| 156 | Deafness, autosomal recessive 107 | Enrichment | WBP2 | 1.87 |
| 157 | Corticobasal syndrome | Enrichment | TBK1 | 1.87 |
| 158 | Prenatal benign hypophosphatasia | Enrichment | ALPL | 1.87 |
| 159 | Deafness, congenital heart defects, and posterior embryotoxon | Enrichment | JAG1 | 1.87 |
| 160 | Periventricular nodular heterotopia 7 | Enrichment | NEDD4L | 1.87 |
| 161 | Encephalopathy, acute, infection-induced 8 | Enrichment | TBK1 | 1.87 |
| 162 | Craniometadiaphyseal osteosclerosis with hip dysplasia | Enrichment | AXIN1 | 1.87 |
| 163 | Congenital heart defects, multiple types, 8, with or without heterotaxy | Enrichment | SMAD2 | 1.87 |
| 164 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.87 |
| 165 | Epithelial basement membrane dystrophy | Enrichment | TGFBI | 1.87 |
| 166 | Heritable thoracic aortic disease | Enrichment | SMAD4 | 1.87 |
| 167 | Syndromic multisystem autoimmune disease due to itch deficiency | Enrichment | ITCH | 1.87 |
| 168 | Lrp5-related primary osteoporosis | Enrichment | LRP5 | 1.87 |
| 169 | Sirenomelia | Enrichment | CDX2 | 1.87 |
| 170 | Oculovertebral syndrome | Enrichment | NR6A1 | 1.87 |
| 171 | Developmental dysplasia of the hip 4 | Enrichment | TRIM33 | 1.87 |
| 172 | Transient cerebral ischemia | Enrichment | NOTCH3 | 1.87 |
| 173 | Aortic arch interruption | Enrichment | NKX2-5 | 1.87 |
| 174 | Primary pulmonary hypertension | Enrichment | BMPR2 | 1.87 |
| 175 | Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1 | Enrichment | NOTCH3 | 1.87 |
| 176 | Pulmonary hypertension | Enrichment | BMPR2 | 1.87 |
| 177 | Turner syndrome | Enrichment | PTCH1 | 1.87 |
| 178 | Familial adenomatous polyposis | Enrichment | APC | 1.87 |
| 179 | Drug- or toxin-induced pulmonary arterial hypertension | Enrichment | BMPR2 | 1.87 |
| 180 | Atrial heart septal defect 7 | Enrichment | NKX2-5 | 1.87 |
| 181 | 7q31 microdeletion syndrome | Enrichment | FOXP2 | 1.87 |
| 182 | Hypogonadotropic hypogonadism 26 with or without anosmia | Enrichment | TCF12 | 1.87 |
| 183 | Congenital plasminogen activator inhibitor type 1 deficiency | Enrichment | SERPINE1 | 1.87 |
| 184 | Monosomy 9q22.3 | Enrichment | PTCH1 | 1.87 |
| 185 | Anorectal malformation | Enrichment | CDX2 | 1.87 |
| 186 | Pax2-related disorder | Enrichment | PAX2 | 1.87 |
| 187 | Gardner syndrome | Enrichment | APC | 1.87 |
| 188 | Osteosclerosis-developmental delay-craniosynostosis syndrome | Enrichment | LRP5 | 1.87 |
| 189 | Lymphedema-posterior choanal atresia syndrome | Enrichment | PTPN14 | 1.87 |
| 190 | 5q22 microdeletion syndrome | Enrichment | APC | 1.87 |
| 191 | Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome | Enrichment | GLI2 | 1.87 |
| 192 | Pash syndrome | Enrichment | NCSTN | 1.87 |
| 193 | Attenuated familial adenomatous polyposis | Enrichment | APC | 1.87 |
| 194 | Huntington's disease-like | Enrichment | PSEN2 | 1.87 |
| 195 | Autosomal dominant nonsyndromic hearing loss 23 | Enrichment | SIX1 | 1.87 |
| 196 | Dislocation of the hip-dysmorphism syndrome | Enrichment | TRIM33 | 1.87 |
| 197 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.87 |
| 198 | Polyvalvular heart disease syndrome | Enrichment | TAB2 | 1.87 |
| 199 | Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome | Enrichment | SHH | 1.87 |
| 200 | Aortic aneurysm, familial thoracic 1 | Enrichment | NOTCH1, SMAD3 | 1.83 |
| 201 | Cleft lip/palate | Enrichment | BMP4, MSX1 | 1.83 |
| 202 | Polydactyly, postaxial, type a1 | Enrichment | GLI1, PTCH1 | 1.78 |
| 203 | Patent foramen ovale | Enrichment | NKX2-5, TAB2 | 1.62 |
| 204 | Ehlers-danlos syndrome | Enrichment | SMAD3, TGFB2 | 1.58 |
| 205 | Ectrodactyly and ectodermal dysplasia without cleft lip/palate | Enrichment | LEF1 | 1.57 |
| 206 | Blepharocheilodontic syndrome 1 | Enrichment | CTNND1 | 1.57 |
| 207 | Papillorenal syndrome | Enrichment | PAX2 | 1.57 |
| 208 | Sveinsson chorioretinal atrophy | Enrichment | TEAD1 | 1.57 |
| 209 | Deafness, unilateral | Enrichment | SIX1 | 1.57 |
| 210 | Cylindromatosis, familial | Enrichment | CYLD | 1.57 |
| 211 | Myhre syndrome | Enrichment | SMAD4 | 1.57 |
| 212 | Camurati-engelmann disease 1 | Enrichment | TGFB1 | 1.57 |
| 213 | Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly | Enrichment | FOXP3 | 1.57 |
| 214 | Van buchem disease | Enrichment | LRP5 | 1.57 |
| 215 | Kyphomelic dysplasia | Enrichment | CCN2 | 1.57 |
| 216 | Pulmonary venoocclusive disease 1, autosomal dominant | Enrichment | BMPR2 | 1.57 |
| 217 | Trichoepithelioma, multiple familial, 1 | Enrichment | CYLD | 1.57 |
| 218 | Alzheimer disease 3 | Enrichment | PSEN1 | 1.57 |
| 219 | Myopathy, x-linked, with postural muscle atrophy | Enrichment | EMD | 1.57 |
| 220 | Pulmonary arteriovenous fistulas | Enrichment | ENG | 1.57 |
| 221 | Loeys-dietz syndrome 2 | Enrichment | TGFBR1 | 1.57 |
| 222 | Hyperparathyroidism 1 | Enrichment | CDC73 | 1.57 |
| 223 | Branchiootic syndrome 3 | Enrichment | SIX1 | 1.57 |
| 224 | Pick disease of brain | Enrichment | PSEN1 | 1.57 |
| 225 | Piebald trait | Enrichment | SNAI2 | 1.57 |
| 226 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | Enrichment | SMAD4 | 1.57 |
| 227 | Solitary median maxillary central incisor | Enrichment | SHH | 1.57 |
| 228 | Orofacial cleft 5 | Enrichment | MSX1 | 1.57 |
| 229 | Adams-oliver syndrome 5 | Enrichment | NOTCH1 | 1.57 |
| 230 | White-sutton syndrome | Enrichment | GLI2 | 1.57 |
| 231 | Robinow syndrome, autosomal dominant 3 | Enrichment | DVL3 | 1.57 |
| 232 | Witkop syndrome | Enrichment | MSX1 | 1.57 |
| 233 | Intellectual developmental disorder with language impairment and with or without autistic features | Enrichment | FOXP1 | 1.57 |
| 234 | Loeys-dietz syndrome 3 | Enrichment | SMAD3 | 1.57 |
| 235 | Adams-oliver syndrome 3 | Enrichment | RBPJ | 1.57 |
| 236 | Spondyloepimetaphyseal dysplasia, li-shao-li type | Enrichment | CCN2 | 1.57 |
| 237 | Charcot-marie-tooth disease, demyelinating, type 4d | Enrichment | NDRG1 | 1.57 |
| 238 | Blepharocheilodontic syndrome 2 | Enrichment | CTNND1 | 1.57 |
| 239 | Alpha-thalassemia/impaired intellectual development syndrome, x-linked | Enrichment | ALPL | 1.57 |
| 240 | Immunodeficiency, common variable, 15 | Enrichment | RUVBL1 | 1.57 |
| 241 | Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures | Enrichment | DLL1 | 1.57 |
| 242 | Neurodevelopmental disorder with developmental delay and with or without motor or speech delay | Enrichment | CUX1 | 1.57 |
| 243 | Inflammatory bowel disease, immunodeficiency, and encephalopathy | Enrichment | TGFB1 | 1.57 |
| 244 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 8 | Enrichment | CYLD | 1.57 |
| 245 | Infantile myofibromatosis | Enrichment | NOTCH3 | 1.57 |
| 246 | Pulmonary venoocclusive disease 1 | Enrichment | BMPR2 | 1.57 |
| 247 | Brooke-spiegler syndrome | Enrichment | CYLD | 1.57 |
| 248 | Retinitis pigmentosa 14 | Enrichment | TEAD3 | 1.57 |
| 249 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.57 |
| 250 | Left ventricular noncompaction 7 | Enrichment | MIB1 | 1.57 |
| 251 | Branchiootic syndrome | Enrichment | SIX1 | 1.57 |
| 252 | Acute basophilic leukemia | Enrichment | MYB | 1.57 |
| 253 | Focal segmental glomerulosclerosis 7 | Enrichment | PAX2 | 1.57 |
| 254 | Split hand-foot malformation | Enrichment | LEF1 | 1.57 |
| 255 | Central precocious puberty | Enrichment | DLK1 | 1.57 |
| 256 | Lipodystrophy, familial partial, type 1 | Enrichment | NOTCH3 | 1.57 |
| 257 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | Enrichment | TBK1 | 1.57 |
| 258 | Osteogenesis imperfecta, type xvii | Enrichment | SPARC | 1.57 |
| 259 | Depressive disorder | Enrichment | NOTCH3 | 1.57 |
| 260 | Camurati-engelmann disease | Enrichment | TGFB1 | 1.57 |
| 261 | Congenital fibrosarcoma | Enrichment | SUFU | 1.57 |
| 262 | Branchiootic syndrome 1 | Enrichment | SIX1 | 1.57 |
| 263 | Inflammatory skin and bowel disease, neonatal, 1 | Enrichment | ADAM17 | 1.57 |
| 264 | Angiocentric glioma | Enrichment | MYB | 1.57 |
| 265 | Hypophosphatasia | Enrichment | ALPL | 1.57 |
| 266 | Congenital heart defects, multiple types, 2 | Enrichment | TAB2 | 1.57 |
| 267 | Periampullary adenoma | Enrichment | APC | 1.57 |
| 268 | Gastric adenocarcinoma and proximal polyposis of the stomach | Enrichment | APC | 1.57 |
| 269 | Alpha thalassemia-x-linked intellectual disability syndrome | Enrichment | ALPL | 1.57 |
| 270 | Hereditary mixed polyposis syndrome | Enrichment | GREM1 | 1.57 |
| 271 | Familial isolated congenital asplenia | Enrichment | NKX2-5 | 1.57 |
| 272 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.57 |
| 273 | Charcot-marie-tooth disease type 4d | Enrichment | NDRG1 | 1.57 |
| 274 | Basal cell nevus syndrome 2 | Enrichment | SUFU | 1.57 |
| 275 | Postaxial polydactyly type b | Enrichment | GLI1 | 1.57 |
| 276 | Deletion 5q35 | Enrichment | NKX2-5 | 1.57 |
| 277 | Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome | Enrichment | TAB2 | 1.57 |
| 278 | Pulmonary venoocclusive disease | Enrichment | BMPR2 | 1.57 |
| 279 | Teratoma | Enrichment | CTNNB1 | 1.57 |
| 280 | B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality | Enrichment | FOXP1 | 1.57 |
| 281 | Osteosclerosis | Enrichment | LRP5 | 1.57 |
| 282 | Renal hypoplasia, bilateral | Enrichment | PAX2 | 1.57 |
| 283 | Isolated radial hemimelia | Enrichment | SHH | 1.57 |
| 284 | Commissural facial cleft | Enrichment | PTCH2 | 1.57 |
| 285 | X-linked emery-dreifuss muscular dystrophy | Enrichment | EMD | 1.57 |
| 286 | Idiopathic/heritable pulmonary arterial hypertension | Enrichment | BMPR2 | 1.57 |
| 287 | Malignant peritoneal mesothelioma | Enrichment | LATS1 | 1.57 |
| 288 | B-lymphoblastic leukemia/lymphoma with t(7;9)(q11.2;p13.2) | Enrichment | PAX5 | 1.57 |
| 289 | Craniosynostosis | Enrichment | GLI2, TCF12 | 1.54 |
| 290 | Microphthalmia | Enrichment | PTCH1, SOX2 | 1.46 |
| 291 | Brittle bone disorder | Enrichment | ALPL, LRP5 | 1.42 |
| 292 | Myeloma, multiple | Enrichment | CYLD, LATS1, YAP1 | 1.41 |
| 293 | Pelvic organ prolapse | Enrichment | TAB2 | 1.40 |
| 294 | Alagille syndrome 1 | Enrichment | JAG1 | 1.40 |
| 295 | Juvenile polyposis syndrome | Enrichment | SMAD4 | 1.40 |
| 296 | Hypophosphatasia, infantile | Enrichment | ALPL | 1.40 |
| 297 | Syndactyly, type iv | Enrichment | SHH | 1.40 |
| 298 | Osteopetrosis, autosomal dominant 1 | Enrichment | LRP5 | 1.40 |
| 299 | Autoimmune disease 1 | Enrichment | FOXD3 | 1.40 |
| 300 | Corneal dystrophy, posterior polymorphous, 3 | Enrichment | ZEB1 | 1.40 |
| 301 | Corneal dystrophy, fuchs endothelial, 6 | Enrichment | ZEB1 | 1.40 |
| 302 | Cone-rod dystrophy 12 | Enrichment | PROM1 | 1.40 |
| 303 | Chromosome 5q14.3 deletion syndrome, distal | Enrichment | NEDD4L | 1.40 |
| 304 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.40 |
| 305 | Holoprosencephaly 7 | Enrichment | PTCH1 | 1.40 |
| 306 | Cenani-lenz syndactyly syndrome | Enrichment | APC | 1.40 |
| 307 | Anus, imperforate | Enrichment | CTNNB1 | 1.40 |
| 308 | Neurodevelopmental disorder with progressive spasticity and brain abnormalities | Enrichment | RUVBL1 | 1.40 |
| 309 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.40 |
| 310 | Precocious puberty, central, 2 | Enrichment | DLK1 | 1.40 |
| 311 | Nail disease | Enrichment | FZD6 | 1.40 |
| 312 | Leukodystrophy and acquired microcephaly with or without dystonia | Enrichment | DLL3 | 1.40 |
| 313 | Hypoplastic or aplastic tibia with polydactyly | Enrichment | SHH | 1.40 |
| 314 | Frontometaphyseal dysplasia | Enrichment | MAP3K7 | 1.40 |
| 315 | Intraocular pressure quantitative trait locus | Enrichment | ZEB1 | 1.40 |
| 316 | Migraine without aura | Enrichment | NOTCH3 | 1.40 |
| 317 | Parathyroid adenoma | Enrichment | CDC73 | 1.40 |
| 318 | Desmoplastic/nodular medulloblastoma | Enrichment | SUFU | 1.40 |
| 319 | Adenoid cystic carcinoma | Enrichment | MYB | 1.40 |
| 320 | Childhood apraxia of speech | Enrichment | FOXP2 | 1.40 |
| 321 | Familial isolated hyperparathyroidism | Enrichment | CDC73 | 1.40 |
| 322 | Colon adenocarcinoma | Enrichment | APC | 1.40 |
| 323 | Advanced sleep phase syndrome | Enrichment | CSNK1D | 1.40 |
| 324 | Neonatal inflammatory skin and bowel disease | Enrichment | ADAM17 | 1.40 |
| 325 | Apc-associated polyposis conditions | Enrichment | APC | 1.40 |
| 326 | Primary ovarian insufficiency | Enrichment | AFP, BMP6, NOTCH2 | 1.35 |
| 327 | Ovarian cancer | Enrichment | APC, AXIN2, CTNNB1, PTCH1 | 1.33 |
| 328 | Acyl-coa dehydrogenase, very long-chain, deficiency of | Enrichment | DVL2 | 1.28 |
| 329 | Emery-dreifuss muscular dystrophy 1, x-linked | Enrichment | EMD | 1.28 |
| 330 | Microphthalmia, syndromic 3 | Enrichment | SOX2 | 1.28 |
| 331 | Schizencephaly | Enrichment | SHH | 1.28 |
| 332 | Sacral defect with anterior meningocele | Enrichment | VANGL1 | 1.28 |
| 333 | Polyposis syndrome, hereditary mixed, 1 | Enrichment | GREM1 | 1.28 |
| 334 | Kagami-ogata syndrome | Enrichment | DLK1 | 1.28 |
| 335 | Persistent mullerian duct syndrome, types i and ii | Enrichment | AMHR2 | 1.28 |
| 336 | Orofaciodigital syndrome iii | Enrichment | CELSR2 | 1.28 |
| 337 | Pilomatrixoma | Enrichment | CTNNB1 | 1.28 |
| 338 | Temple syndrome | Enrichment | DLK1 | 1.28 |
| 339 | Alazami syndrome | Enrichment | CTNNB1 | 1.28 |
| 340 | Emery-dreifuss muscular dystrophy | Enrichment | EMD | 1.28 |
| 341 | Dowling-degos disease | Enrichment | PSENEN | 1.28 |
| 342 | Orofacial cleft | Enrichment | LRP6 | 1.28 |
| 343 | Retinopathy of prematurity | Enrichment | LRP5 | 1.28 |
| 344 | Cerebrovascular disease | Enrichment | NOTCH3 | 1.28 |
| 345 | Persistent mullerian duct syndrome | Enrichment | AMHR2 | 1.28 |
| 346 | Hereditary progressive cardiac conduction defect | Enrichment | NKX2-5 | 1.28 |
| 347 | Eyelid coloboma | Enrichment | FZD5 | 1.28 |
| 348 | Non-syndromic bicoronal craniosynostosis | Enrichment | TCF12 | 1.28 |
| 349 | Genetic central precocious puberty in male | Enrichment | DLK1 | 1.28 |
| 350 | Vitreoretinopathy | Enrichment | LRP5 | 1.28 |
| 351 | Orofacial clefting syndrome | Enrichment | LRP6 | 1.28 |
| 352 | Middle aortic syndrome | Enrichment | JAG1 | 1.28 |
| 353 | Cleft lip and alveolus | Enrichment | MSX1 | 1.28 |
| 354 | Oculomotor apraxia | Enrichment | SUFU | 1.28 |
| 355 | Lens coloboma | Enrichment | FZD5 | 1.28 |
| 356 | Lymphoma, mucosa-associated lymphoid type | Enrichment | FOXP1 | 1.18 |
| 357 | Arrhythmogenic right ventricular dysplasia, familial, 1 | Enrichment | TGFB3 | 1.18 |
| 358 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 | Enrichment | NOTCH3 | 1.18 |
| 359 | Rhabdomyosarcoma 2 | Enrichment | PAX3 | 1.18 |
| 360 | Chondrosarcoma, extraskeletal myxoid | Enrichment | TCF12 | 1.18 |
| 361 | Familial adenomatous polyposis 1 | Enrichment | APC | 1.18 |
| 362 | Ventricular septal defect 1 | Enrichment | BMP7 | 1.18 |
| 363 | Robinow syndrome, autosomal dominant 2 | Enrichment | DVL3 | 1.18 |
| 364 | Congenital heart defects, multiple types, 4 | Enrichment | BMP7 | 1.18 |
| 365 | Fuchs' endothelial dystrophy | Enrichment | ZEB1 | 1.18 |
| 366 | Arrhythmogenic right ventricular dysplasia 1 | Enrichment | TGFB3 | 1.18 |
| 367 | Aplasia cutis congenita | Enrichment | DLL4 | 1.18 |
| 368 | Vascular dementia | Enrichment | NOTCH3 | 1.18 |
| 369 | Cleft upper lip | Enrichment | MSX1 | 1.18 |
| 370 | Dementia | Enrichment | PSEN1 | 1.18 |
| 371 | Herpes simplex virus encephalitis | Enrichment | TBK1 | 1.18 |
| 372 | Coloboma of choroid and retina | Enrichment | FZD5 | 1.18 |
| 373 | Diffuse cutaneous systemic sclerosis | Enrichment | CCN2 | 1.18 |
| 374 | Persistent truncus arteriosus | Enrichment | NKX2-5 | 1.18 |
| 375 | Connective tissue disease | Enrichment | NOTCH1, SMAD3 | 1.17 |
| 376 | Autism | Enrichment | FOXP1, SHH, TCF7L2 | 1.14 |
| 377 | Developmental dysplasia of the hip 1 | Enrichment | TRIM33 | 1.11 |
| 378 | Coloboma of optic nerve | Enrichment | FZD5 | 1.11 |
| 379 | Branchiootorenal syndrome 1 | Enrichment | SIX1 | 1.11 |
| 380 | Corneal dystrophy, posterior polymorphous, 1 | Enrichment | ZEB1 | 1.11 |
| 381 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.11 |
| 382 | Conotruncal heart malformations | Enrichment | NKX2-5 | 1.11 |
| 383 | Split-hand/foot malformation 1 | Enrichment | LEF1 | 1.11 |
| 384 | Type 1 diabetes mellitus | Enrichment | FOXP3 | 1.11 |
| 385 | Anterior segment dysgenesis 5 | Enrichment | BMP4 | 1.11 |
| 386 | Congenital anomalies of kidney and urinary tract 1 | Enrichment | PAX2 | 1.11 |
| 387 | Inflammatory bowel disease 25, autosomal recessive | Enrichment | TGFB1 | 1.11 |
| 388 | Renal hypoplasia | Enrichment | PAX2 | 1.11 |
| 389 | Pulmonary fibrosis | Enrichment | PARN | 1.11 |
| 390 | Adrenocortical carcinoma | Enrichment | CTNNB1 | 1.11 |
| 391 | Double outlet right ventricle | Enrichment | NKX2-5 | 1.11 |
| 392 | Limited scleroderma | Enrichment | CCN2 | 1.11 |
| 393 | Hoyeraal-hreidarsson syndrome | Enrichment | PARN | 1.11 |
| 394 | Il10-related early-onset inflammatory bowel disease | Enrichment | TGFB1 | 1.11 |
| 395 | Classic ehlers-danlos syndrome | Enrichment | TGFBR1 | 1.11 |
| 396 | Waardenburg syndrome | Enrichment | PAX3 | 1.11 |
| 397 | Cleft lip with or without cleft palate | Enrichment | CTNND1 | 1.11 |
| 398 | Breast cancer | Enrichment | APC, CDC73, PTCH2 | 1.10 |
| 399 | Left ventricular noncompaction | Enrichment | MIB1, NKX2-5 | 1.10 |
| 400 | Multiple endocrine neoplasia, type i | Enrichment | CDC73 | 1.04 |
| 401 | Osteogenesis imperfecta, type ii | Enrichment | MESD | 1.04 |
| 402 | Waardenburg syndrome, type 1 | Enrichment | PAX3 | 1.04 |
| 403 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | NKX2-5 | 1.04 |
| 404 | Waardenburg syndrome, type 2e | Enrichment | SNAI2 | 1.04 |
| 405 | Semantic dementia | Enrichment | PSEN1 | 1.04 |
| 406 | Branchiootorenal syndrome | Enrichment | SIX1 | 1.04 |
| 407 | Motor neuron disease | Enrichment | TBK1 | 1.04 |
| 408 | Congenital hydrocephalus | Enrichment | PTCH1 | 1.04 |
| 409 | Overgrowth syndrome | Enrichment | PTCH1 | 1.04 |
| 410 | Dilated cardiomyopathy | Enrichment | EMD, NKX2-5, TAB2 | 1.03 |
| 411 | Hemochromatosis, type 1 | Enrichment | BMP6 | 0.99 |
| 412 | Leber congenital amaurosis 1 | Enrichment | PROM1 | 0.99 |
| 413 | Spondylocostal dysostosis 1, autosomal recessive | Enrichment | DLL3 | 0.99 |
| 414 | Neuroblastoma | Enrichment | LIN28B | 0.99 |
| 415 | Combined pituitary hormone deficiency | Enrichment | GLI2 | 0.99 |
| 416 | Type 2 diabetes mellitus | Enrichment | RBPJ, TCF7L2 | 0.96 |
| 417 | Gastric cancer | Enrichment | APC, SMAD4 | 0.95 |
| 418 | Tracheoesophageal fistula with or without esophageal atresia | Enrichment | CELSR2 | 0.94 |
| 419 | Ellis-van creveld syndrome | Enrichment | GLI1 | 0.94 |
| 420 | Leukemia, acute lymphoblastic 3 | Enrichment | PAX5 | 0.94 |
| 421 | Cystic kidney disease | Enrichment | PAX2 | 0.94 |
| 422 | Colonic benign neoplasm | Enrichment | APC | 0.94 |
| 423 | Familial thoracic aortic aneurysm and dissection | Enrichment | SMAD3 | 0.94 |
| 424 | Behavioral variant of frontotemporal dementia | Enrichment | PSEN1 | 0.94 |
| 425 | Hydrops fetalis | Enrichment | FOXP3 | 0.94 |
| 426 | Hereditary breast carcinoma | Enrichment | APC, CDC73 | 0.93 |
| 427 | Cat eye syndrome | Enrichment | FZD5 | 0.90 |
| 428 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 | Enrichment | TBK1 | 0.90 |
| 429 | Peters-plus syndrome | Enrichment | BMP4 | 0.90 |
| 430 | Stroke, ischemic | Enrichment | NOTCH3 | 0.90 |
| 431 | Stickler syndrome | Enrichment | BMP4 | 0.90 |
| 432 | Familial colorectal cancer | Enrichment | GREM1 | 0.90 |
| 433 | Isolated tracheo-esophageal fistula | Enrichment | CELSR2 | 0.90 |
| 434 | Pectus excavatum | Enrichment | TGFBR1 | 0.86 |
| 435 | Frontotemporal dementia 1 | Enrichment | PSEN1 | 0.86 |
| 436 | Meningioma, familial | Enrichment | SUFU | 0.86 |
| 437 | Leukemia, acute lymphoblastic | Enrichment | PAX5 | 0.86 |
| 438 | Nanophthalmos | Enrichment | SOX2 | 0.86 |
| 439 | Atrial heart septal defect | Enrichment | NKX2-5 | 0.86 |
| 440 | Interatrial communication | Enrichment | NKX2-5 | 0.86 |
| 441 | Autosomal dominant non-syndromic intellectual disability | Enrichment | CUX1, DLL1 | 0.84 |
| 442 | Epicanthus | Enrichment | ACVR1 | 0.82 |
| 443 | Renal hypodysplasia/aplasia 3 | Enrichment | BMP4 | 0.82 |
| 444 | Meningioma | Enrichment | SUFU | 0.82 |
| 445 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | TGFB3 | 0.82 |
| 446 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | TGFB3 | 0.82 |
| 447 | Familial isolated dilated cardiomyopathy | Enrichment | PSEN1, PSEN2 | 0.80 |
| 448 | Osteogenesis imperfecta, type iv | Enrichment | SPARC | 0.79 |
| 449 | Alzheimer's disease | Enrichment | PSEN1 | 0.79 |
| 450 | Osteoporosis | Enrichment | LRP5 | 0.76 |
| 451 | Periventricular nodular heterotopia | Enrichment | NEDD4L | 0.76 |
| 452 | Heart disease | Enrichment | NKX2-5 | 0.76 |
| 453 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | TGFB3 | 0.76 |
| 454 | Isolated macular dystrophy | Enrichment | PROM1 | 0.76 |
| 455 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 | Enrichment | PSEN1, TBK1 | 0.74 |
| 456 | Rare genetic intellectual disability | Enrichment | FOXP1 | 0.74 |
| 457 | Rhabdomyosarcoma | Enrichment | PTCH1 | 0.71 |
| 458 | Alzheimer disease, familial, 1 | Enrichment | PSEN1 | 0.69 |
| 459 | Cleft palate, isolated | Enrichment | AMER1 | 0.69 |
| 460 | Interstitial lung disease 2 | Enrichment | PARN | 0.69 |
| 461 | Heart, malformation of | Enrichment | JAG1 | 0.67 |
| 462 | Charcot-marie-tooth disease type 4 | Enrichment | NDRG1 | 0.67 |
| 463 | Neuromuscular disease | Enrichment | EMD | 0.67 |
| 464 | Arteriovenous malformations of the brain | Enrichment | ENG | 0.64 |
| 465 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | EMD | 0.64 |
| 466 | Esophageal atresia/tracheoesophageal fistula | Enrichment | CELSR2 | 0.64 |
| 467 | Dyskeratosis congenita | Enrichment | PARN | 0.64 |
| 468 | Focal segmental glomerulosclerosis | Enrichment | PAX2 | 0.63 |
| 469 | Centronuclear myopathy | Enrichment | FOXP3 | 0.61 |
| 470 | Skin disease | Enrichment | NCSTN | 0.59 |
| 471 | Precursor t-cell acute lymphoblastic leukemia | Enrichment | MYB | 0.57 |
| 472 | Familial atrial fibrillation | Enrichment | NKX2-5 | 0.56 |
| 473 | Pancreatic cancer | Enrichment | SMAD4 | 0.54 |
| 474 | Developmental and epileptic encephalopathy 1 | Enrichment | CSNK1E | 0.54 |
| 475 | Hydrops fetalis, nonimmune | Enrichment | FZD6 | 0.53 |
| 476 | Auditory neuropathy | Enrichment | NOTCH3 | 0.53 |
| 477 | Strabismus | Enrichment | FOXP1 | 0.51 |
| 478 | Bladder cancer | Enrichment | CTNNB1 | 0.49 |
| 479 | Hirschsprung disease 1 | Enrichment | AXIN2 | 0.49 |
| 480 | Differentiated thyroid carcinoma | Enrichment | TRIM33 | 0.49 |
| 481 | Stargardt disease 1 | Enrichment | PROM1 | 0.48 |
| 482 | Isolated joubert syndrome | Enrichment | SUFU | 0.48 |
| 483 | Non-immune hydrops fetalis | Enrichment | FZD6 | 0.47 |
| 484 | Hereditary retinal dystrophy | Enrichment | JAG1, LRP5, PAX2, PROM1, TEAD3 | 0.46 |
| 485 | Fundus dystrophy | Enrichment | JAG1, LRP5, PAX2, PROM1, TEAD3 | 0.46 |
| 486 | Cystic fibrosis | Enrichment | TGFB1 | 0.45 |
| 487 | Usher syndrome | Enrichment | PROM1 | 0.44 |
| 488 | Severe combined immunodeficiency | Enrichment | STK4 | 0.44 |
| 489 | Leber plus disease | Enrichment | PROM1, TEAD3 | 0.44 |
| 490 | Cakut | Enrichment | PAX2 | 0.43 |
| 491 | Genetic steroid-resistant nephrotic syndrome | Enrichment | PAX2 | 0.43 |
| 492 | Systemic lupus erythematosus | Enrichment | ENG | 0.39 |
| 493 | Congenital nervous system abnormality | Enrichment | CTNNB1, PSEN1 | 0.38 |
| 494 | Nervous system disease | Enrichment | CTNNB1, PSEN1 | 0.38 |
| 495 | Myopathy | Enrichment | EMD | 0.38 |
| 496 | Charcot-marie-tooth disease | Enrichment | NDRG1 | 0.37 |
| 497 | Nephrotic syndrome | Enrichment | PAX2 | 0.36 |
| 498 | West syndrome | Enrichment | CSNK1E | 0.35 |
| 499 | Thrombocytopenia | Enrichment | SMAD4 | 0.32 |
| 500 | Body mass index quantitative trait locus 11 | Enrichment | DIXDC1 | 0.31 |
| 501 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | SIX1 | 0.30 |
| 502 | Hereditary breast ovarian cancer syndrome | Enrichment | PTCH1 | 0.28 |
| 503 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | GLI2 | 0.27 |
| 504 | Cone-rod dystrophy 2 | Enrichment | PROM1 | 0.22 |
| 505 | Rare genetic deafness | Enrichment | PAX3 | 0.18 |
| 506 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | WBP2 | 0.15 |
| 507 | Autism spectrum disorder | Enrichment | TCF12 | 0.11 |
| 508 | Microcephaly | Enrichment | CTNNB1 | 0.09 |
| 509 | Complex neurodevelopmental disorder | Enrichment | TCF7L2 | 0.09 |
| 510 | Retinitis pigmentosa | Enrichment | PROM1 | 0.02 |